Conard J, Gradelet A, Samama M
Ann Biol Clin (Paris). 1981;39(2):81-3.
The estimation of Stuart Factor (Factor X) with a new synthetic substrate S-2337, and the prothrombin time were compared in 91 patients treated with oral anticoagulants for more than one month. There was a good correlation between the two tests (r = 0.79 and 0.81 depending on the thromboplastin used). The results of out short study suggest a therapeutic zone between 20 p cent and 32 p cent of factor X but these values require confirmation. This method may constitute a progress in the laboratory supervision of treatment with coumarin derivatives for it permits better standardisation of the results and may easily be adapted to an autoanalyser.
采用新型合成底物S - 2337对91例接受口服抗凝剂治疗超过1个月的患者进行了斯图尔特因子(因子X)测定,并与凝血酶原时间进行了比较。两项检测之间存在良好的相关性(根据所用凝血活酶不同,r分别为0.79和0.81)。我们简短研究的结果表明,因子X在20%至32%之间可能为治疗区间,但这些数值尚需确认。该方法可能在香豆素衍生物治疗的实验室监测方面取得了进展,因为它能使结果更好地标准化,并且可能很容易适配自动分析仪。